glp 1 agonist anti inflammatory 2024 Multiple Sclerosis Highlight GLP-1 drugs calm inflammation beyond

Delivering a peptide drug orally is challenging because the GI tract degrades proteins

These same states report obesity rates near or above 40%, among the highest in the country

These findings suggest that survodutide has the potential to reduce liver fibrosis and improve liver function in patients with NASH, making it a promising therapeutic option for this complex liver disease [89]

Intracranial pressure outcomes Direct assessment of ICP was limited to the single included RCT by Mitchell et al

reported a significantly increased risk of aspiration pneumonia in GLP-1 RA users undergoing gastrointestinal endoscopy, especially with propofol sedation, likely due to impaired airway protection reflexes [110]

GIP activation enhances insulin sensitivity and contributes to fat metabolism